|
1）Miyamoto K, Haito-Sugino S, Kuwahara S, et al. Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies. J Pharm Sci. 2011; 100: 3719-30
|
|
|
|
2）Berndt T, Kumar R. Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda). 2009; 24: 17-25
|
|
|
|
|
|
3）Tatsumi S, Kaneko I, Shiozaki Y, et al. Regulation of renal phosphate handling: Inter-organ communication in health and disease. J Bone Miner Metab. 2015 (in press)
|
|
|
|
|
|
4）Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15: 2208-18
|
|
|
|
|
|
5）Weinman EJ, Lederer ED. PTH-mediated inhibition of the renal transport of phosphate. Exp Cell Res. 2012; 318: 1027-32
|
|
|
|
|
|
6）Murer H, Hernando N, Forster I, et al. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev. 2000; 80: 1373-409
|
|
|
|
|
|
7）Tenenhouse HS. Phosphate transport: molecular basis, regulation and pathophysiology. J Steroid Biochem Mol Biol. 2007; 103: 572-7
|
|
|
|
|
|
8）Donate-Correa J, Muros-de-Fuentes M, Mora-Fernandez C, et al. FGF23/Klotho axis: phosphorus, mineral metabolism and beyond. Cytokine Growth Factor Rev. 2012; 23: 37-46
|
|
|
|
|
|
9）Berndt TJ, Schiavi S, Kumar R.“Phosphatonins”and the regulation of phosphorus homeostasis. Am J Physiol Renal Physiol. 2005; 289: F1170-82
|
|
|
|
|
|
10）Martin A, David V, Quarles LD. Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev. 2012; 92: 131-55
|
|
|
|
|
|
11）Hallan SI, Matsushita K, Sang Y, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA. 2012; 308: 2349-60
|
|
|
|
|
|
12）Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011; 305: 1119-27
|
|
|
|
|
|
13）Isakova T, Wahl P, Vargas GS, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011; 79: 1370-8
|
|
|
|
|
|
14）Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int. 2012; 82: 737-47
|
|
|
|
|
|
15）Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006; 444: 770-4
|
|
|
|
|
|
16）Kurosu H, Ogawa Y, Miyoshi M, et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem. 2006; 281: 6120-3
|
|
|
|
|
|
17）Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clinical Invest. 2011; 121: 4393-408
|
|
|
|
|
|
18）Gattineni J, Alphonse P, Zhang Q, et al. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4. Am J Physiol Renal Physiol. 2014; 306: F351-8
|
|
|
|
|
|
19）Gattineni J, Twombley K, Goetz R, et al. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. Am J Physiol Renal Physiol. 2011; 301: F371-7
|
|
|
|
|
|
20）Salem RR, Tray K. Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg. 2005; 241: 343-8
|
|
|
|
|
|
21）Nafidi O, Lepage R, Lapointe RW, D’Amour P. Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg. 2007; 245: 1000-2
|
|
|
|
|
|
22）Lee HW, Suh KS, Kim J, et al. Hypophosphatemia after live donor right hepatectomy. Surgery. 2008; 144: 448-53
|
|
|
|
|
|
23）Nafidi O, Lapointe RW, Lepage R, et al. Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia. Ann Surg. 2009; 249: 824-7
|
|
|
|
|
|
24）Nomura K, Tatsumi S, Miyagawa A, et al. Hepatectomy-related hypophosphatemia: a novel phosphaturic factor in the liver-kidney axis. J Am Soc Nephrol. 2014; 25: 761-72
|
|
|
|
|
|
25）Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem. 2004; 279: 50754-63
|
|
|
|
|
|
26）Garten A, Petzold S, Korner A, et al. Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol Metab. 2009; 20: 130-8
|
|
|
|
|